Carregant...
Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice
Multiple myeloma is an incurable malignancy of plasma B-cells. Traditional chemotherapeutic regimes often induce initial tumor regression; however, virtually all patients eventually succumb to relapse caused by either reintroduction of disease during autologous transplant or expansion of chemotherap...
Guardat en:
| Publicat a: | Mol Ther Oncolytics |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5142464/ https://ncbi.nlm.nih.gov/pubmed/27933316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2016.32 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|